News | Hypertension

YMCA of the USA (Y-USA) and the American Heart Association (AHA) are combining efforts to help more people better manage their blood pressure. Beginning this spring, more than 100 clinics participating in the Target: BP initiative will be able to refer qualified patients to enroll at no cost in the YMCA’s Blood Pressure Self-Monitoring program.

Home April 05, 2018
Home
News | Stroke

April 5, 2018 — Medical imaging company Brainomix has attracted £7m ($9.8 million) of investment to bring its artificial ...

Home April 05, 2018
Home
News | Cardiovascular Business

April 5, 2018 — Diagnostic and Interventional Cardiology (DAIC) magazine received the 2018 Jesse H. Neal Award for Best ...

Home April 05, 2018
Home
News | Heart Failure

The Ohio State University Wexner Medical Center will establish the nation’s first center dedicated to treating those with heart failure and arrhythmia with gifts totaling $18 million from Bob and Corrine Frick.

Home April 04, 2018
Home
News

Boston Scientific Corp. announced the acquisition of Securus Medical Group Inc., a privately-held company that has developed a thermal monitoring system for the continuous measurement of esophageal temperature. Boston Scientific has been an investor in Securus since 2016, and the transaction price for the remaining stake not already owned consists of $40 million in cash up-front, as well as up to $10 million in contingent payments based on regulatory achievements and commercial milestones.

Home April 04, 2018
Home
Technology | Computed Tomography (CT)

April 4, 2018 — The U.S. Food and Drug Administration (FDA) has cleared the Somatom Edge Plus computed tomography (CT) ...

Home April 04, 2018
Home
Technology | Structural Heart Occluders

April 3, 2018 — Following the unprecedented Gore REDUCE Clinical Study conclusion that closure of patent foramen ovale ...

Home April 03, 2018
Home
News | Cardiovascular Business

GE Healthcare announced the sale of its Value-Based Care Division — including its software assets for Enterprise Financial Management, Ambulatory Care Management and Workforce Management — to private equity investment firm Veritas Capital. The sale, expected to be completed in third quarter 2018, was valued at $1.05 billion in cash.

Home April 02, 2018
Home
American College of Cardiology, #ACC18
Feature | Dave Fornell

Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine ...

Home April 02, 2018
Home
Technology | Ventricular Assist Devices (VAD)

Abiomed Inc. announced that it received U.S. Food and Drug Administration (FDA) Pre-Market Approval (PMA) for its Impella CP heart pump with SmartAssist, utilizing an optical sensor. The company said these advances in technology and software are designed to improve productivity, ease of use and patient management to ensure optimal patient care.

Home April 02, 2018
Home
News | Stroke

Revised guidelines for the nonsurgical, image-guided interventional treatment of acute ischemic stroke will ensure patients receive the right treatment at the right time. The updated guidelines, endorsed by the Society of Interventional Radiology (SIR) and 11 other medical societies, were published in the April edition of SIR’s peer-reviewed journal, the Journal of Vascular and Interventional Radiology (JVIR).

Home April 02, 2018
Home
News | Ultrasound Imaging

Philips in partnership with Innovative Imaging Technologies (IIT) announced an industry-first integrated tele-ultrasound solution on Philips’ Lumify portable ultrasound system powered by IIT’s Reacts collaborative platform. This innovation connects clinicians around the globe in real time by turning a compatible smart device into an integrated tele-ultrasound solution, combining two-way audio-visual calls with live ultrasound streaming.

Home March 30, 2018
Home
News | Stroke

March 30, 2018 — The Marcus Foundation has donated $15 million to establish the Marcus Stroke Network, a coordinated and ...

Home March 30, 2018
Home
News | Heart Valve Technology

LivaNova PLC announced the first patient enrollment in the Perceval Valve Clinical study for Chinese Registration (“PERFECT”) Trial. The study is a pre-market, prospective, single-arm trial. The PERFECT trial is being conducted to demonstrate the safety and effectiveness of the Perceval sutureless aortic heart valve when used to replace a diseased native or malfunctioning prosthetic aortic valve in the indicated Chinese population for tissue heart valve replacement.

Home March 30, 2018
Home
News | Congenital Heart

March 30, 2018 — Bariatric surgery is predicted to cut in half the risk of premature heart disease and stroke in teens ...

Home March 30, 2018
Home
Subscribe Now